Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.7B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$593M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$460M |
| 5 |
Netflix
NFLX
|
+$323M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$478M |
| 2 |
RTN
Raytheon Company
RTN
|
+$318M |
| 3 |
Merck
MRK
|
+$257M |
| 4 |
Johnson & Johnson
JNJ
|
+$251M |
| 5 |
Qualcomm
QCOM
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.89% |
| 2 | Healthcare | 14.18% |
| 3 | Financials | 11.46% |
| 4 | Consumer Discretionary | 10.84% |
| 5 | Industrials | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
Oil-Dri
ODC
$1.3B
| $1.54M | ﹤0.01% |
88,578
-1,098
| -1% | -$19K |
|
2802
Clean Energy Fuels
CLNE
$403M
| $1.53M | ﹤0.01% |
691,663
+34,113
| +5% | +$68.9K |
|
2803
iShares Micro-Cap ETF
IWC
$1.51B
| $1.53M | ﹤0.01% |
17,578
-3,758
| -18% | -$294K |
|
2804
Paysign
PAYS
$739M
| $1.53M | ﹤0.01% |
158,086
+2,123
| +1% | +$15.7K |
|
2805
Syndax Pharmaceuticals
SNDX
$1.74B
| $1.53M | ﹤0.01% |
103,541
+20,919
| +25% | +$319K |
|
2806
Rio Tinto
RIO
$156B
| $1.53M | ﹤0.01% |
27,257
-5,885
| -18% | -$298K |
|
|
HTB
2807
HomeTrust Bancshares
HTB
$834M
| $1.53M | ﹤0.01% |
95,697
-4,229
| -4% | -$63.6K |
|
2808
Scholar Rock
SRRK
$6.39B
| $1.53M | ﹤0.01% |
83,970
+20,045
| +31% | +$342K |
|
2809
LifeVantage
LFVN
$81M
| $1.53M | ﹤0.01% |
113,073
-198
| -0.2% | -$2.75K |
|
|
CWBC
2810
Community West Bancshares
CWBC
$704M
| $1.53M | ﹤0.01% |
99,213
-6,466
| -6% | -$89.5K |
|
2811
Plains All American Pipeline
PAA
$16.8B
| $1.52M | ﹤0.01% |
172,531
+17,280
| +11% | +$147K |
|
|
GCAP
2812
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $1.52M | ﹤0.01% |
252,979
-21,652
| -8% | -$133K |
|
|
CYBE
2813
DELISTED
Cyberoptics Corp
CYBE
| $1.52M | ﹤0.01% |
47,213
+14,502
| +44% | +$405K |
|
2814
Amalgamated Financial
AMAL
$1.52B
| $1.51M | ﹤0.01% |
119,582
-12,340
| -9% | -$131K |
|
|
BDSI
2815
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $1.51M | ﹤0.01% |
346,205
+17,052
| +5% | +$76.6K |
|
2816
CytomX Therapeutics
CTMX
$734M
| $1.51M | ﹤0.01% |
181,084
-14,147
| -7% | -$131K |
|
|
FCBP
2817
DELISTED
First Choice Bancorp Common Stock
FCBP
| $1.51M | ﹤0.01% |
91,939
-7,613
| -8% | -$111K |
|
|
LITS
2818
Lite Strategy Inc
LITS
$30.4M
| $1.5M | ﹤0.01% |
18,217
+4,271
| +31% | +$259K |
|
2819
iShares Morningstar Growth ETF
ILCG
$3.29B
| $1.5M | ﹤0.01% |
32,015
+4,005
| +14% | +$174K |
|
|
QTNT
2820
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $1.5M | ﹤0.01% |
5,072
+3,758
| +286% | +$1.08M |
|
2821
MetroCity Bankshares
MCBS
$1.04B
| $1.5M | ﹤0.01% |
104,654
+4,140
| +4% | +$47K |
|
|
BRG
2822
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $1.5M | ﹤0.01% |
185,441
-171
| -0.1% | -$1.14K |
|
2823
Zentalis Pharmaceuticals
ZNTL
$254M
| $1.5M | ﹤0.01% |
+31,162
| New | +$1.2M |
|
2824
Civista Bancshares
CIVB
$591M
| $1.49M | ﹤0.01% |
96,884
-5,238
| -5% | -$76.2K |
|
|
PEI
2825
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $1.49M | ﹤0.01% |
73,032
-24,729
| -25% | -$446K |
|
Similar funds
Bank of New York Mellon's Q2 2020 Portfolio in Review
As of Q2 2020, Bank of New York Mellon held 4,266 positions worth $375B, up 24% from $302B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Bank of New York Mellon's Q2 2020 filing shows 170 new, 1,923 increased, 1,788 reduced and 190 closed positions. Its largest new stake was Otis Worldwide: 5,903,383 shares worth $336M. The largest sale was Allergan plc, an estimated $478M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2020 buy was Otis Worldwide: 5,903,383 shares worth $336M.
- Bank of New York Mellon added most to Amazon in Q2 2020, an estimated $1.7B increase.
- Bank of New York Mellon's biggest Q2 2020 reduction was Merck, cutting an estimated $257M.
- Bank of New York Mellon fully exited Allergan plc in Q2 2020, selling an estimated $478M.
- Bank of New York Mellon's ten largest holdings make up 21% of its $375B portfolio in Q2 2020.
- Bank of New York Mellon opened 170 new positions and closed 190 in Q2 2020.
- Bank of New York Mellon's portfolio value rose 24% quarter-over-quarter to $375B.
Based on Bank of New York Mellon's 13F filing for Q2 2020, filed 12 Aug 2020.